Not applicableUnknownNCT04280133What this trial is testingCAR T-CELL Therapy Educational Video TrialWho this might be right forHematologic MalignancyCAR-T Cell Therapy Massachusetts General Hospital 80
Early research (Phase 1)Study completedNCT00693433What this trial is testingTemsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple MyelomaWho this might be right forRefractory Multiple MyelomaStage I Multiple MyelomaStage II Multiple Myeloma+1 more National Cancer Institute (NCI) 15
Large-scale testing (Phase 3)Study completedNCT00176852What this trial is testingStem Cell Transplant for HemoglobinopathyWho this might be right forSickle Cell DiseaseThalassemiaSevere Congenital Neutropenia+2 more Masonic Cancer Center, University of Minnesota 22
Not applicableStudy completedNCT00996047What this trial is testingS9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic CancersWho this might be right forLeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms SWOG Cancer Research Network 3,341
Testing effectiveness (Phase 2)Study completedNCT01744665What this trial is testingA Study That Switched Patients From Imatinib to Nilotinib and Then Was Followed by Treatment CessationWho this might be right forCML Novartis Pharmaceuticals 59
Testing effectiveness (Phase 2)Looking for participantsNCT05745714What this trial is testingHEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesWho this might be right forAcute Lymphoblastic Leukemia, in RelapseLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent+2 more Princess Maxima Center for Pediatric Oncology
Not applicableStudy completedNCT00899899What this trial is testingResistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or RemissionWho this might be right forLeukemia Children's Oncology Group 135
Early research (Phase 1)Study completedNCT02900716What this trial is testingSafety Study of BTK Inhibitor, DTRMWXHS-12, Used Singly or in Combination, in CLL and B-cell LymphomasWho this might be right forChronic Lymphocytic LeukemiaB-Cell Lymphoma Zhejiang DTRM Biopharma 48
Not applicableStudy completedNCT05212233What this trial is testingFinancial Difficulty in Patients With Blood CancerWho this might be right forChronic Lymphocytic LeukemiaMultiple Myeloma UNC Lineberger Comprehensive Cancer Center 218
Not applicableLooking for participantsNCT06773871What this trial is testingFeasibility and Safety of Exercise in Patients With Low-risk Myeloid Cancers and Precursor ConditionsWho this might be right forMyelodysplastic SyndromeCytopenia Rigshospitalet, Denmark 36
Testing effectiveness (Phase 2)Study completedNCT03469934What this trial is testingProof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic AsthmaWho this might be right forEosinophilic Asthma AnaptysBio, Inc. 25
Testing effectiveness (Phase 2)Study completedNCT02963493What this trial is testingMelphalan Flufenamide (Melflufen) Plus Dexamethasone in Patients With Relapsed or Refractory Multiple MyelomaWho this might be right forMultiple Myeloma Oncopeptides AB 157
Testing effectiveness (Phase 2)Ended earlyNCT01542684What this trial is testingStudy of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)Who this might be right forLeukemia M.D. Anderson Cancer Center 8
Large-scale testing (Phase 3)Ended earlyNCT01376700What this trial is testingEarly Prophylaxis Immunologic Challenge (EPIC) StudyWho this might be right forHemophilia A Baxalta now part of Shire 22
Early research (Phase 1)Ended earlyNCT00234000What this trial is testingAzacitidine and Arsenic Trioxide in Treating Patients With Myelodysplastic SyndromesWho this might be right forLeukemiaMyelodysplastic Syndromes Jonsson Comprehensive Cancer Center 1
Not applicableUnknownNCT01889407What this trial is testingIdarubicin Overcomes MDR1 Induced Chemoresistance With Higher Induction Remission Rate and Quality Than Daunorubicin in Acute Myeloid Leukemia PatientsWho this might be right forAcute Myeloid Leukemia Nanfang Hospital, Southern Medical University 94
Testing effectiveness (Phase 2)Ended earlyNCT02685111What this trial is testingIntermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC)Who this might be right forBreast CancerNeutropeniaFebrile Neutropenia Asan Medical Center 22
Large-scale testing (Phase 3)Study completedNCT00469144What this trial is testingIV Busulfan With Allo-BMT: Study for Patients With Acute Myelogenous Leukemia and Myelodysplastic SyndromeWho this might be right forMyelodysplastic SyndromeLeukemiaAcute Myeloid Leukemia M.D. Anderson Cancer Center 233
Early research (Phase 1)Study completedNCT03892044What this trial is testingDuvelisib and Nivolumab in Treating Patients With Richter Syndrome or Transformed Follicular LymphomaWho this might be right forChronic Lymphocytic LeukemiaRecurrent Diffuse Large B-Cell LymphomaRefractory Diffuse Large B-Cell Lymphoma+5 more David Bond, MD 7
Large-scale testing (Phase 3)Enrolling By InvitationNCT06544109What this trial is testingVenetoclax for Prevention of Differentiation Syndrom in Acute Promyelocytic Leukemia PatientsWho this might be right forAcute Promyelocytic Leukemia The First Affiliated Hospital of Soochow University 98